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Objective: To conduct the cloning identiﬁcation and characterization of the sequence of
human IL-17A promoter so as to analyze the regulatory mechanism of the gene
expression of IL-17.
Methods: First of all, the potential promoter region of IL-17A was found by means of
the bioinformatics methods. Then, it was cloned into the reporter vector with PCR
technique. Finally, the activity of the test promoter was determined by dual luciferase
reporter system.
Results: Two transcriptional start points of the upper region, 600 bp and 1000 bp, of IL-
17A were obtained by PCR clone and proved to have certain activities by dual luciferase
reporter system. Also, they could be activated by IL-17A activator STAT3, which could
start the expression of the reported gene.
Conclusions: Clone established the regulatory region of human IL-17A promoter, which
provided bases to the subsequent function research.1. Introduction
IL-17 is a kind of proinﬂammatory cytokine derived from
TH17 cells which is quite different to Th1 and Th2 cell subsets.
IL-17 axis is a hot point in basic and clinical studies at present,
since it play an important role in host defense, autoimmune
diseases and the course of tumors [1].
The discovery of IL-17 gene and IL-17 protein goes back to
the CTLA-8 cloned by activated rodent T hybridoma, and they
are found to have a high homology with the 13th ORF of Herpes
virus saimiri. Later, researchers found that CTLA-8 protein
could be secreted to the outside of the cell and induce the
expression of IL-6 and IL-8 by activating the NF-kB pathway.Meanwhile, it can activate the proliferation of T cells so that it is
named IL-17 [2,3].
The biological function of IL-17 depends on the forms of the
homodimer or heterodimer (built by intramolecular disulﬁde
bond). At present, it is found that IL-17A and IL-17F are the
main members of the IL-17 family. The others are IL-17B, IL-
17C, IL-17D and IL-17E [4]. Among them, the function of IL-
17B, IL-17C and IL-17D remains undeﬁned, but the expres-
sions of proinﬂammatory factors such as TNFa, IL-6 and IL-1b
can be induced by the proinﬂammatory effect of IL-17E, IL-17A
and IL-17F [5,6].
IL-17 plays a key role in the host defense against infections.
For instance, it works through mucosal immunity in bacterial
and fungal infection [7]. IL-6 induced by IL-17 has a quite strong
positive feedback promotion effect on the differentiation of
TH17 cells and the activation of acute phase response and
complement [8]. IL-17 can also adjust neutrophilic granulocyte
by inducing and promoting G-CSF and CXCL. On the other
hand, IL-17 can gather monocytes (by inducing CCL2 and
CCL7) by induced proteins with chemotactic activity such as
dendritic cells to target them to the mucosal surface. It-17 can
also raise the expression of antimicrobial peptide, the latter can
kill the invaded pathogens directly and strengthen the immune
function of the host [9]. The above explains the effects of
pathogenic TH17 and IL-17 on autoimmunity diseases.cle under the CC BY-NC-ND license (http://
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discovered that serum IL-17A increases in patients with inﬂu-
enza virus infection, which also reﬂects in patients infected with
macrophage and helicobacter pylori infection after infecting by
mycobacterium tuberculosis [10–12]. Therefore, the regulatory
analysis of IL-17A in researches of common infectious dis-
eases is very important. There are many different molecular
mechanisms which are found to control the activation and
expression of IL-17, such as STAT3, Oct1, CNS2, etc. [13–15].
Other researchers and we have found in the early researchers
that the expressions of many immune response-related inﬂam-
matory factors were adjusted and controlled by DNA methylated
modiﬁcation after bacterial or viral infection [16–18]. In order to
further study whether the expression of IL-17A is regulated and
controlled by that mechanism, it is necessary to explore the
DNA methylated modiﬁcation and the combination of tran-
scription factors in the promoter region. So, in this study, we
cloned the regulatory region of IL-17A promoter ﬁrstly and then
analyzed and identiﬁed its biological function to provided basis
for the follow-up researches.
2. Materials and methods
2.1. Cells
Human embryonic kidney-derived HEK293T cell strain
medium consisted of DMEM containing 10% fetal bovine serum
and 100 U/mL penicillin and 100 mg/L streptomycin. The
required temperature: 37 C, incubator: 5% CO2. The synthesis
of primers and DNA sequencing were completed by Invitrogen.
Escherichia coli DH5 strains used for clone construction were
kept in our lab.
2.2. Reagents
Instrumental enzymes used for clone were bought from
Takara; plasmid extraction, gel extraction, product puriﬁcation
and non-endotoxin hyperpure plasmid midi kit were purchased
from Axygen; luciferase detection reagent Dual-Luciferase Re-
porter Assay Systemp, GL3 and pRL plasma were bought from
Promega; cell culture media, Lipofeatmin2000 were provided by
Invitrogen; and other analytical reagents were purchased from
Shanghai Pharmaceutical Group.
2.3. Bioinformatics analysis
The gene sequence of human IL-17A was obtained from
National Center for Biotechnology Information (NCBI). The
promoter was predicted and the transcription factor wasTable 1
The activation analysis of IL-17A promoter.
Promoter pSTAT3
0 mg 3 mg
pGL3 10.52 ± 2.48 12.38 ± 1.67
p17A-600 24.37 ± 2.33 103.58 ± 15.27
p17A-1000 37.12 ± 1.98 104.65 ± 12.52
The activation of IL-17A promoter analyzed the RLA intensity of luciferas
vector STAS3 co-transfected 293T and compared with the 0 of the same granalyzed by using online database TFSEARCH and Promoter
2.0 Prediction Server.
2.4. Primers design and PCR ampliﬁcation
According to the predicted sequence, two primer segments
compounded by Invitrogen, 600 bp and 1000 bp, were designed
(Table 1). The template was given PCR ampliﬁcation with the
human-derived genome. The reaction conditions were 95 C for
5 min, 94 C for 30 s, 58 C for 30 s and 72 C for 70 s, which
would repeat 30 times. PCR instrument of Eppendorf was used.
The products of PCR were detected by 1% sepharose gel.
2.5. The construction of luciferase vector
The products of PCR, 600 bp and 1000 bp puriﬁed in elec-
trophoresis with restriction enzyme Sac I and Xho I double
digested gel, and pGL3-Basic plasma were used to purify,
connect and transform competence Escherichia coli DH5a cells.
Bacteria liquid polymerase chain reaction and positive clones
were detected by screening, double enzyme digestion and
sequencing. Luciferase reporter vector containing IL-17A pro-
moter region was acquired and named p17A-600 and 1000.
2.6. Cell transfection
HEK293T cells were planked on 24-well plates (4 × 105) and
cultured to a certain concentration (70–80%). Then, p17A-600,
p17A-1000 and pRL were applied for co-transfection. The
mass ratio was 20:1. The co-transfection volumes of pCMV-
STAT3 were 3 mg and 5 mg. Lipofectamine 2000 (Invitrogen)
was employed for the transfection. The application amount of
plasma was in accordance with the instruction book. OPTI-
MEM medium was used for the transfection. Four hours later,
normal serum medium was applied.
2.7. The detection of the activity of promoter
After transfected for 48 h, the activity of luciferase was tested
by chemiluminescence apparatus. Every step was conducted in
accordance with the instruction of Dual-Luciferase Reporter
Assay System strictly. Every sample received 3 parallel hole
experiments. The relative intensity of ﬂuorescence (RLA, refers
to the ratio of ﬂuorescence signal strength, i.e. catalytic reaction
substrates of luciferase) was used to start the promoter activity.
SPSS16 software was used for statistical analysis.
Mean ± standard deviation was used to express measurement
data. The comparison was tested by t-test. Differences were
statistically signiﬁcant (P < 0.05).P (3 vs. 0) P (5 vs. 0)
5 mg
13.01 ± 2.02 0.339 0.259
84.93 ± 14.32 0.009 0.014
123.18 ± 17.17 0.008 0.009
e after p17A-600, p17A-1000 and pGL3 empty vectors and expression
oup.
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3.1. Bioinformatics analysis
The gene sequence of IL-17A was obtained from NCBI. The
region between the 30 bp after the transcription start site which
was set to be the starting point and the 5000 bp in the upper
region which was designed to be the section was cut out and
analyzed. After analyzed by Promoter 2.0, it was found that the
highest score appeared in the previous 600 bp and 1000 bp
regions and following the TFSEARCH Search analysis indicated
that a large amount of transcription activator binding sites such
as OCT1, STAT3, ROR and AP1 also existed in the previous
600 bp and 1000 bp regions. So, we cloned these two regions at
the same time, respectively.
3.2. The construction of the reporter vector of IL-17A
promoter
Human peripheral blood-originated genome was used as a
template and two pairs of primers were used respectively for PCR
ampliﬁcation. Promoter segments of IL-17Awith expected size of
about 600 bp and 1000 bpwere found to be ampliﬁed successfully
after the products had been tested with electrophoresis by 1%
agarose gel. When targeted segments were connected with pGL3
vector and transformed and identiﬁed by colony polymerase chain
reaction, positive clones appeared, and its sequencing result was
equivalent to the reference sequence of NCBI, which further
implied the success of the construction of the two luciferase re-
porter vectors (containing promoter region of IL-17).
3.3. Analysis of the promoter activity of Il-17A
P17A-600, p17A-1000 or pGL3 empty vectors and internal
control pRL were used to transfect HEK293T cells, which aimed
to verify the activity of the constructed pIL-17A vector. After
48 h, the relative intensity of ﬂuorescence was used for the
detection. The results showed that pGL3 vector had no activity,
while p17A-600 and p17A-1000 can promote the activity of
luciferase signiﬁcantly, which indicated the success of the con-
struction of pIL-17A promoter vector.
3.4. The activation analysis of IL-17A promoter
In order to further detect the response of constructed p17A-
600 and p17A-1000 towards IL-17A activating agent, STAT3,
p17A-600 and p17A-1000 were co-transfected to observe the
activity of IL-17A. The result showed that after the activation
analysis of IL-17A promoter, the RLA intensity of luciferase
after p17A-600, p17A-1000 and pGL3 empty vectors and
expression vector STAS3 co-transfected 293T were all
compared with the 0 of the same group, **P < 0.01 (Table 1).
Without STAT3, the values of p17A-600 and p17A-1000 agreed
with the about above validation. However, after adding 3 mg and
5 mg pCMV-STAT3 expression plasma for co-transfection, the
activities of p17A-600 and p17A-1000 increased 3–5 times,
which indicated that the cloned IL-17 possessing binding points
of STAT3 had effects of promotion and regulation and further
proved that the cloned ampliﬁed regions also contained bio-
logical function which could be used in the subsequent mech-
anism analysis and researches.4. Discussion
In many physiological processes of infection and immunity,
IL-17 is an very important inﬂammatory factor, so that it is very
important to study the signal transduction mechanism worked by
IL-17. In this study, we carried out a cloning identiﬁcation of IL-
17A promotion regions, which was the most important promoter
region of the IL-17 family. Firstly, we obtained the possible
region, 600 bp and 1000 bp of the upper region, by bioinfor-
matics prediction. Next, they were cloned to luciferase reporter
vector pGL3. Finally, luciferase report system was used to prove
that the segment contained promoter activity and was sensitive
to IL-17 activating reagent STAT3. All these results demon-
strated that we have cloned IL-17A containing promoter activity
regions, which provided basis for the follow-up studies.
In recent years, 6 numbers of the IL-17 family and 5 numbers
of the IL-17 receptors (IL-17RA/B/C/D/E) family have been
discovered, but only the proinﬂammatory cytokines of IL-17A,
IL-17E and IL-17F are conﬁrmed, and IL-17A is the most
important one [19]. Hence, the regulation and control of the
expression of IL-17 remains very important. In studies of im-
mune cells, the characteristic transcription factor RORgt of IL-
17 was found. It was found by knocking out RORgt of gene
in mice that IL-17 cells could not be induced by TGFb and IL-6,
and IL-17 could be induced speciﬁcally (over-expressed RORgt)
without affecting IFNg, which indicated that the key transcrip-
tion factor of IL-17 controlling differentiation was RORgt [20].
A research also found that without IL-6 and TGF-b IkBf
could adjust and control the differentiation of TH17 and the
expression of IL-17 by co-working with ROR nuclear receptor
[21].
With the intensive study of TH17 cells, other factors have
been found successively, positive regulation factors such as
STAT3, IRF4 and NLRP3 and negative regulation factors such
as Ets-1, STAT5 and Foxp3. The activating agent STAT3 used
in this study was a positive regulation factor of IL-17A, too. It
could strengthen the activity of IL-17 promoter at the cellular
level. Besides, STAT3 was also the downstream regulation
pathway of IL-17. New researches have revealed that IL-17A
would facilitate the transformation from chronic pancreatitis to
pancreatic cancer by REG3b-JAK2-STAT3 inﬂammatory
corpuscle pathways [22].
In addition, epigenetic is a branch of genetics referring to the
inheritable changes of genetic expression (under the condition of
the unchanged gene nucleotide sequences), which has become
the hot point of in the ﬁeld of biomedicine. The epigenetic
mechanism mainly includes DNA methylation, histone acety-
lation, microRNA, genomic imprinting, etc. Epigenetic is also
found in the research area of IL-17 and TH17. Multiple re-
searches have found that methylation participates in adjusting
and controlling the expression of IL-17 [23]. When IL-6 and
TGF-b facilitate the differentiation of Naive CD4(+) T cells
towards TH17, conserved intergenic elements and DNA
methylation work together to regulate the expression of IL-17
gene blocks. Methylation in the IL-17 promoter region would
lead to the decrease of the combination of STAT3 transcription
factors, which would further affect the expression of IL-27 [24].
Similarly, histone acetylation was also found to work in this
process, which indicated the phenomenon of H3K27
demethylation and H3K4 methylation [24]. Extended researches
have revealed that histone H3 lysine-27 demethylase Jmjd3
plays a key role in the differentiation process of TH17. Jmjd3
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factors and declined the level of methylation [25]. In patients
with acute asthma, Estrogen and progesterone enhanced the
expression and secretion of IL-23/IL-23 receptor signaling and
IL-17A by decreasing the expression of let-7f microRNA [26].
Due to the strong effect expressing by IL-17 in induced in-
ﬂammations, especially the effects of fending off pathogens and
inducement and maintenance of chronic inﬂammations which
have attached more and more attentions. In this study, we
focused on the epigenetic regulation after infection, so we pre-
liminary obtained the potential promoter clone with biological
activity by cloning and functionally identiﬁed the promoter
regulatory region of IL-17A, which provided working founda-
tions to the subsequent molecular mechanism researches.
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